MANGROVE PARTNERS IM, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001535392

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q3 2025 · 178 positions · Total reported value $1.35B · Top-10 concentration 46.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 143 new · 48 cut · 205 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, MANGROVE PARTNERS IM, LLC disclosed 178 equity positions with a combined reported value of $1.35B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.7% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2025 were ECDAW ($150.76M), INDV ($66.12M), RIO ($65.92M). By sector, the heaviest allocations are Financials 19.1%, Consumer Discretionary 18.9%. Versus the prior quarter, allocation shifted toward Other (+5.5pp), Industrials (+3.3pp) and away from Consumer Discretionary (-1.1pp), Materials (-1.3pp).

Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 25% of names.

The largest new positions opened in Q3 2025 were FLYW ($39.29M), PCG ($39.16M), BIO ($35.57M).

Of the 205 positions fully exited versus the prior quarter, the largest were WDC ($52.74M), TIGO ($40.44M), AER ($39.89M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • FLYW FLYWIRE CORPORATION · $39.29M
  • PCG PG&E CORP · $39.16M
  • BIO BIO RAD LABS INC · $35.57M
  • ELME ELME COMMUNITIES · $34.48M
  • BILL BILL HOLDINGS INC · $31.15M
  • IBIT ISHARES BITCOIN TRUST ETF · $18.86M
  • REX REX AMERICAN RES CORP · $16.12M
  • AXIN AXIOM INTELLIGENCE AC CORP 1 · $8.96M

Fully Exited (vs previous quarter)

  • WDC WESTERN DIGITAL CORP · prev qtr: $52.74M
  • TIGO MILLICOM INTL CELLULAR S A · prev qtr: $40.44M
  • AER AERCAP HOLDINGS NV · prev qtr: $39.89M
  • IJR ISHARES TR · prev qtr: $25.45M
  • UBS UBS GROUP AG · prev qtr: $17.84M
  • AUR AURORA INNOVATION INC · prev qtr: $14.75M
  • PPLI PEOPLE INC · prev qtr: $12.64M
  • HE HAWAIIAN ELEC INDS INC MTN B · prev qtr: $6.58M

Insider Transactions (Form 4)

Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-78070 (status: Approved), registered 2013-05-20
  • Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: mangrovepartners.com

Portfolio Structure

  • 426 positions · $1.52B reported value (Q2 2026)
  • Top 10 holdings = 38.1% of reported value
  • Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
  • Average position size: $3.57M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 18.5%
  • Information Technology 13.9%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
  • 127 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 19.1%
Health Care 16.9%
Technology 5.9%
Materials 5.6%
Other 20.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 978.99K $150.76M 11.14%
11.14%
Reduce
2 2.74M $66.12M 4.88%
4.88%
Add
3 998.66K $65.92M 4.87%
4.87%
Hold
4 1.33M $59.99M 4.43%
4.43%
Add
5 496.97K $57.20M 4.23%
4.23%
Add
6 575.91K $48.57M 3.59%
3.59%
Add
7 1.44M $48.46M 3.58%
3.58%
Add
8 5.47M $47.95M 3.54%
3.54%
Add
9 2.34M $47.23M 3.49%
3.49%
Add
10 1.05M $39.33M 2.91%
2.91%
Reduce
11 2.90M $39.29M 2.90%
2.90%
New
12 2.60M $39.16M 2.89%
2.89%
New
13 1.18M $37.26M 2.75%
2.75%
Reduce
14 1.19M $36.60M 2.70%
2.70%
Add
15 126.85K $35.57M 2.63%
2.63%
New
16 2.05M $34.48M 2.55%
2.55%
New
17 478.41K $31.78M 2.35%
2.35%
Add
18 588.01K $31.15M 2.30%
2.30%
New
19 2.88M $27.09M 2.00%
2.00%
Add
20 671.69K $27.06M 2.00%
2.00%
Add
21 260.99K $25.80M 1.91%
1.91%
Add
22 3.68M $24.39M 1.80%
1.80%
Add
23 290.12K $18.86M 1.39%
1.39%
New
24 526.55K $16.12M 1.19%
1.19%
New
25 7.79M $16.05M 1.19%
1.19%
Reduce
26 4.60M $9.71M 0.72%
0.72%
Hold
27 900.00K $8.96M 0.66%
0.66%
New
28 2.53M $6.31M 0.47%
0.47%
Hold
29 178.71K $5.28M 0.39%
0.39%
Reduce
30 491.64K $4.95M 0.37%
0.37%
Add
31 486.90K $4.84M 0.36%
0.36%
New
32 450.00K $4.73M 0.35%
0.35%
Hold
33 450.00K $4.72M 0.35%
0.35%
Add
34 475.00K $4.72M 0.35%
0.35%
New
35 450.00K $4.67M 0.34%
0.34%
New
36 450.00K $4.64M 0.34%
0.34%
Add
37 450.00K $4.60M 0.34%
0.34%
Add
38 450.00K $4.59M 0.34%
0.34%
Hold
39 450.00K $4.58M 0.34%
0.34%
New
40 450.00K $4.56M 0.34%
0.34%
New
41 450.00K $4.55M 0.34%
0.34%
Hold
42 450.00K $4.55M 0.34%
0.34%
Add
43 450.00K $4.54M 0.34%
0.34%
Add
44 450.00K $4.52M 0.33%
0.33%
Hold
45 450.00K $4.52M 0.33%
0.33%
New
46 450.00K $4.51M 0.33%
0.33%
New
47 450.00K $4.49M 0.33%
0.33%
New
48 450.00K $4.49M 0.33%
0.33%
New
49 450.00K $4.48M 0.33%
0.33%
New
50 450.00K $4.47M 0.33%
0.33%
New

FAQ

What did MANGROVE PARTNERS IM, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, MANGROVE PARTNERS IM, LLC reported 178 equity positions worth $1.35B in aggregate; its largest disclosed positions were ECDAW ($150.76M), INDV ($66.12M), RIO ($65.92M).

How large is MANGROVE PARTNERS IM, LLC's portfolio?

MANGROVE PARTNERS IM, LLC reported $1.35B of long equity holdings across 178 positions as of 2025-Q3. Top-10 holdings account for 46.7% of reported value.

What is MANGROVE PARTNERS IM, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/mangrove-partners-im/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →